Oxford BioDynamics (Oxford BioDynamics) Gross Margin % : 42.06% (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Oxford BioDynamics Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Oxford BioDynamics's Gross Profit for the six months ended in Sep. 2023 was $0.15 Mil. Oxford BioDynamics's Revenue for the six months ended in Sep. 2023 was $0.36 Mil. Therefore, Oxford BioDynamics's Gross Margin % for the quarter that ended in Sep. 2023 was 42.06%.

The historical rank and industry rank for Oxford BioDynamics's Gross Margin % or its related term are showing as below:

OXBOF' s Gross Margin % Range Over the Past 10 Years
Min: -36.4 Med: 52.16 Max: 75.32
Current: 52.16

During the past 11 years, the highest Gross Margin % of Oxford BioDynamics was 75.32%. The lowest was -36.40%. And the median was 52.16%.

OXBOF's Gross Margin % is ranked worse than
57.76% of 741 companies
in the Biotechnology industry
Industry Median: 59.43 vs OXBOF: 52.16

Oxford BioDynamics had a gross margin of 42.06% for the quarter that ended in Sep. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Oxford BioDynamics was 0.00% per year.

Oxford BioDynamics Gross Margin % Historical Data

The historical data trend for Oxford BioDynamics's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Gross Margin % Chart

Oxford BioDynamics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Gross Margin %

Get a 7-Day Free Trial

48.35

-36.38

75.29

52.14

Oxford BioDynamics Semi-Annual Data
	Sep13	Sep14	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Gross Margin %	Get a 7-Day Free Trial														760.80	-	44.87	65.54	42.06

Competitive Comparison of Oxford BioDynamics's Gross Margin %

For the Biotechnology subindustry, Oxford BioDynamics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford BioDynamics's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioDynamics's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's Gross Margin % falls into.

Oxford BioDynamics Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Oxford BioDynamics's Gross Margin for the fiscal year that ended in Sep. 2023 is calculated as

Gross Margin % (A: Sep. 2023 )	=	Gross Profit (A: Sep. 2023 )	/	Revenue (A: Sep. 2023 )
	=	0.3	/	0.631
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.631 - 0.302)	/	0.631
	=	52.14 %

Oxford BioDynamics's Gross Margin for the quarter that ended in Sep. 2023 is calculated as

Gross Margin % (Q: Sep. 2023 )	=	Gross Profit (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	0.2	/	0.359
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.359 - 0.208)	/	0.359
	=	42.06 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Oxford BioDynamics (OTCPK:OXBOF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Oxford BioDynamics had a gross margin of 42.06% for the quarter that ended in Sep. 2023 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Oxford BioDynamics Gross Margin % Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioDynamics (Oxford BioDynamics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (OTCPK:OXBOF) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

OBD:UK

Address

Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB

Website

https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.